| Segment / region | Type | Fiscal year | Currency | Revenue (millions) | Share of revenue |
|---|---|---|---|---|---|
| UNITED STATES | Region | 2025 | USD | 36,510.0 | 56.2% |
| EMEA | Region | 2025 | USD | 14,580.0 | 22.4% |
| Latin America | Region | 2025 | USD | 3,410.0 | 5.3% |
| Asia Pacific | Region | 2025 | USD | 2,983.0 | 4.6% |
| International | Region | 2025 | USD | 2,878.0 | 4.4% |
| JAPAN | Region | 2025 | USD | 2,711.0 | 4.2% |
| CHINA | Region | 2025 | USD | 1,939.0 | 3.0% |
| UNITED STATES | Region | 2024 | USD | 32,277.0 | 50.3% |
| EMEA | Region | 2024 | USD | 14,041.0 | 21.9% |
| CHINA | Region | 2024 | USD | 5,494.0 | 8.6% |
| Latin America | Region | 2024 | USD | 3,459.0 | 5.4% |
| JAPAN | Region | 2024 | USD | 3,280.0 | 5.1% |
| Asia Pacific | Region | 2024 | USD | 3,058.0 | 4.8% |
| International | Region | 2024 | USD | 2,559.0 | 4.0% |
| Pharmaceutical segment | Region | 2023 | USD | 53,583.0 | 89.1% |
| Animal Health segment | Region | 2023 | USD | 5,625.0 | 9.4% |
| Other Segments | Region | 2023 | USD | 907.0 | 1.5% |
| UNITED STATES | Region | 2022 | USD | 27,206.0 | 45.9% |
| EMEA | Region | 2022 | USD | 14,493.0 | 24.5% |
| CHINA | Region | 2022 | USD | 5,191.0 | 8.8% |
| JAPAN | Region | 2022 | USD | 3,629.0 | 6.1% |
| Asia Pacific | Region | 2022 | USD | 3,614.0 | 6.1% |
| Latin America | Region | 2022 | USD | 2,582.0 | 4.4% |
| International | Region | 2022 | USD | 2,568.0 | 4.3% |
| UNITED STATES | Region | 2021 | USD | 22,425.0 | 46.0% |
| EMEA | Region | 2021 | USD | 13,341.0 | 27.4% |
| CHINA | Region | 2021 | USD | 4,378.0 | 9.0% |
| JAPAN | Region | 2021 | USD | 2,726.0 | 5.6% |
| Asia Pacific | Region | 2021 | USD | 2,407.0 | 4.9% |
| Latin America | Region | 2021 | USD | 2,206.0 | 4.5% |
| International | Region | 2021 | USD | 1,221.0 | 2.5% |
| UNITED STATES | Region | 2020 | USD | 21,027.0 | 43.8% |
| EMEA | Region | 2020 | USD | 13,600.0 | 28.3% |
| CHINA | Region | 2020 | USD | 3,624.0 | 7.6% |
| JAPAN | Region | 2020 | USD | 3,376.0 | 7.0% |
| Asia Pacific | Region | 2020 | USD | 2,864.0 | 6.0% |
| Latin America | Region | 2020 | USD | 2,274.0 | 4.7% |
| International | Region | 2020 | USD | 1,229.0 | 2.6% |
| Pharmaceutical segment | Product | 2025 | USD | 58,142.0 | 89.4% |
| Animal Health segment | Product | 2025 | USD | 6,354.0 | 9.8% |
| Other Segments | Product | 2025 | USD | 515.0 | 0.8% |
| Pharmaceutical segment | Product | 2024 | USD | 57,400.0 | 89.5% |
| Animal Health segment | Product | 2024 | USD | 5,877.0 | 9.2% |
| Other Segments | Product | 2024 | USD | 891.0 | 1.4% |
| Pharmaceutical segment | Product | 2023 | USD | 53,583.0 | 89.1% |
| Animal Health segment | Product | 2023 | USD | 5,625.0 | 9.4% |
| Other Segments | Product | 2023 | USD | 907.0 | 1.5% |
| Pharmaceutical segment | Product | 2022 | USD | 52,005.0 | 87.7% |
| Animal Health segment | Product | 2022 | USD | 5,550.0 | 9.4% |
| Other Segments | Product | 2022 | USD | 1,728.0 | 2.9% |
| Pharmaceutical segment | Product | 2021 | USD | 42,754.0 | 87.8% |
| Animal Health segment | Product | 2021 | USD | 5,568.0 | 11.4% |
| Other Segments | Product | 2021 | USD | 382.0 | 0.8% |
| Pharmaceutical segment | Product | 2020 | USD | 43,021.0 | 90.1% |
| Animal Health segment | Product | 2020 | USD | 4,703.0 | 9.9% |
| Other Segments | Product | 2020 | USD | 23.0 | 0.1% |
Product and geographic breakdowns describe the same revenue from different perspectives and should not be added together.
